Nephros Receives Notice of Intention to Delist from AMEX (PR Newswire via Yahoo! Finance) PDF Print

Nephros, Inc. , a medical device company developing and marketing filtration products for therapeutic applications, infection control, and water purification, today announced that it has received notice from the NYSE Alternext US LLC , regarding AMEX's intention to delist the Company's common stock due to noncompliance with certain continued listing standards.

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.